Breakthrough

How Exercise Outperforms Every Supplement

Apr 11, 2026 · Updated Apr 26, 2026 · 8 min read

This is not a motivational essay. It is a direct comparison of effect sizes. When you place the measured biological effects of regular exercise next to the measured effects of any supplement — including the best-supported ones — exercise wins on the outcomes that actually matter, usually by a wide margin.

Cardiovascular Health

A pooled analysis of accelerometer-measured activity in 116,221 adults (Saint-Maurice 2020 PMID 32219361) found that meeting U.S. physical activity guidelines (~150 minutes moderate-to-vigorous activity per week) was associated with about a 30% lower risk of all-cause mortality. The 2024 Lancet Global Health analysis of 196 countries (Strain 2024 PMID 38942499) confirms a similar dose-response. The best-supported cardiovascular supplement — pharmaceutical-grade icosapent ethyl (purified EPA) at 4 g/day in the REDUCE-IT trial (Bhatt 2019 PMID 30415628) — cut major adverse cardiovascular events by 25% in a high-risk statin-treated population. The dose far exceeds what typical fish-oil capsules deliver. Exercise produces a larger absolute risk reduction across a much broader population, at zero financial cost.

Exercise vs. Top Supplements

Effect size for same endpoint

All-cause mortality — 150 min/wk exerciseHR 0.69
−31%
All-cause mortality — creatineno signal
~0%
Depression — exercise (MDD meta)SMD 0.75
Large
Depression — omega-3 (EPA)SMD 0.25
Small–mid
HbA1c — exercise 150 min/wk−0.7%
Large
HbA1c — berberine 1.5 g−0.5%
Modest
In every head-to-head of cheap lifestyle interventions vs. popular supplements, the lifestyle intervention wins on effect size. Stacks do not substitute for movement.

Cognitive Function, Inflammation, and Metabolic Health

A 1-year aerobic exercise RCT in 120 older adults (Erickson 2011 PMID 21282661) found a roughly 2% increase in hippocampal volume — reversing the typical age-related decline of about 1–2% per year. No supplement has shown structural brain-volume gains in a controlled human trial. Regular moderate-intensity exercise also lowers C-reactive protein (CRP), IL-6, and TNF-alpha through multiple mechanisms; the best-studied anti-inflammatory supplement (fish oil) shows consistently smaller effect sizes (Tabrizi 2020 PMID 32227340). The Diabetes Prevention Program (Knowler 2002 PMID 11832527) found that a structured lifestyle program (diet plus 150 min/week activity, ~7% weight loss) reduced new type 2 diabetes by 58% over 2.8 years — better than metformin (31%) and better than any supplement that has ever been tested for that endpoint.

Depression and the Correct Framing

A 2024 BMJ network meta-analysis of 218 RCTs in 14,170 adults (Noetel 2024 PMID 38355154) found that walking, jogging, and strength training produced moderate-to-large reductions in depression symptoms — on par with cognitive behavioral therapy and SSRIs. Ashwagandha, the best-evidenced supplement for anxiety, shows effect sizes that are meaningfully smaller than aerobic exercise produces. The right framing: supplements are add-ons to a physically active life, not replacements for one.

Sources

  1. Saint-Maurice PF, et al. “Association of Daily Step Count and Step Intensity With Mortality Among US Adults.” JAMA, 2020;323(12):1151-1160. PMID 32219361.
  2. Bhatt DL, et al. “Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT).” NEJM, 2019;380:11-22. PMID 30415628.
  3. Erickson KI, et al. “Exercise training increases size of hippocampus and improves memory.” PNAS, 2011;108(7):3017-3022. PMID 21282661.
  4. Knowler WC, et al. “Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (DPP).” NEJM, 2002;346:393-403. PMID 11832527.
  5. Noetel M, et al. “Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials.” BMJ, 2024;384:e075847. PMID 38355154.
  6. Strain T, et al. “National, regional, and global trends in insufficient physical activity among adults from 2000 to 2022.” Lancet Global Health, 2024. PMID 38942499.

Reviewed against 6 peer-reviewed sources.